16:02 Dec 20
Divi's Laboratories Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Divi's Laboratories Ltd.
57/100 High Financial Strength
Quality14/100 Expensive Valuation
Valuation53/100 Technically Neutral
TechnicalSWOT
Strength
8
Weakness
9
Opportunity
1
Threat
1
1.55L
Market Cap (Cr)
84.54
PE Ratio
11.32
Price to Book Ratio
43.77
RSI
20.39 %
Net Profit Margin
Rating Based on 6 Analysts
Buy
17%
Hold
33%
Sell
50%
Sell
Analyst Price Target
The average price target is 5017.83 with a high estimate of 6812 and low estimate of 3150
Current 5846.75
Disclaimer:The analysis information is for reference only and does not constitude an investment recommendation
SWOT
Download Our App On:
